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Rezumat 
 
Obiectivul lucrării a fost stabilirea úi validarea unei metode HPLC cu detecĠie în ultraviolet (UV) pentru 
determinarea simultană a oxitocinei úi clorbutanolului din produse medicinale veterinare injectabile. 
Metoda se bazează pe prescripĠiile din monografia pentru soluĠie concentrată de oxitocină din 
Farmacopeia Europeană. Separarea cromatografică s-a făcut pe o coloană Syn Chropack RP100 C18 (250 
x 4,6mm, 5 ȝm) cu fază mobilă compusă din soluĠie A: tampon fosfat acid de sodiu 0,13 M úi soluĠie B: 
acetonitril-apă (1:1, v/v) cu gradient de eluĠie (30 % B pentru 1 min, 30 % la 60 % B în 30 min, revenire la 
concentraĠia iniĠialăúi echilibrare 15 min înainte de înjecĠia următoare), la un debit de 1 ml/min úi detecĠie 
la 220 nm. Timpul de retenĠie pentru oxitocinăúi clorbutanol au fost de circa 15 min úi respectiv 26 min. 
Produúii de degradare al oxitocinei au eluat la timpi de retenĠie mai mici de 14 min. RezoluĠia dintre 
oxitocină úi cel mai apropiat pic s-a încadrat în cerinĠele Farmacopoeii de minim 1,5. S-a evaluat 
linearitatea metodei între 2,5 UI/ml – 20 UI/ml oxitocinăúi 1,25 mg/ml – 10 mg/ml clorbutanol. În aceste 
domenii metoda s-a dovedit lineară pentru ambii componenĠi, coeficienĠii de corelaĠie ai curbelor de 
calibrare fiind mai mari de 0,9950. Metoda a fost validată în termeni de selectivitate, linearitate, exactitate 
úi fidelitate. 
 
Abstract 
 
The objective of this work was to establish and validate a HPLC method with UV detection for 
simultaneous determination of oxytocin and clorobutanol in veterinary injectable formulations. The 
method is based on European Pharmacopoeia monograph for oxytocin concentrated solution. 
Chromatographic separation was achieved on a Syn Chropack RP100 C18 column (250 x 4,6mm, 5 ȝm) 
with a mobile phase consisting of solutia A: sodium dihydrogen phosphate buffer 0,13 M and solution B: 
acetonitrile-water (1:1, v/v) with gradient elution (30 % B for 1 min, 30 % B to 60 % B in 30 min, return to 
initial concentration and echilibration for 15 min before the following injection), at a flowrate of 1 ml/min 
and detection at 220 nm. The retention times for oxytocin and clorobutanol were about 15 min and 26 min 
respectively. The degradation products of oxytocin eluted at retention times smaller than 14 min. The 
resolution between oxytocin and the nearest impurity fulfilled the USP monograph requirements of at 
least 1,5. The linearity of the method has been settled from 2,5 UI/ml to 20 UI/ml for oxytocin and 1,25 
mg/ml  to 10 mg/ml for clorobutanol. In these ranges the corelation coefficients were higher than 0,9950. 
The method allows the separation of oxytocin from degradation products and clorobutanol and could be 
applicable to quality control of injectable products containing oxytocin and clorobutanol. The method 
was validated in terms of selectivity, linearity, precision and accuracy.  
 
Introduction 
Oxytocin is a nanopeptid produced by 
synthesis  structurally  similar  hormone 
produced by the posterior lobe of the pituitary 
gland. It is used in veterinary medicine in the 
form of injectable solutions, mainly as a 
stimulant on the uterus and favoring 
lactation. The injectable solutions are 
generally formulated to contain 5 IU/ml to 10 
IU/ml oxytocin and respectively 5 mg/ml 
chlorobutanol as a preservative. 
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have been demonstrated selective and 
sensitive for determining the oxytocin. 
Oxytocin proper separation of other 
polypeptides were obtained on reverse 
phase columns of various sizes, and particle 
sizes, under izocratic or with gradient, 
generally using as the mobile phase 
phosphate buffer / acetonitrile and detection 
at 210-220 nm. 
Chlorobutanol is one of the antimicrobial 
agents approved for use in pharmaceuticals.  
Farmacopoeia’s  requirement  is  to 
declare the contents of the antimicrobial 
agent and demonstrate that it is present in 
the amount stated in the limits of ± 20%. 
Most of the published methods for 
determination of chlorobutanol are GC. 
HPLC is an alternative methods and has 
been shown straight and selective. 
The aim of this work is the validation of a 
HPLC  method  for  simultaneous 
determination of oxytocin and chlorobutanol 
from injectable solutions, fit for routine 
control of veterinary drugs’ analizys. 
 
Materials and method 
 
Standards and reactives 
Oxytocin Ph. Eur. (PN 70002) containing 
oxytocin ethyl acetate with an 524 IU/mg 
activity it was used, chlorobutanol was 
obtained from Sigma HPLC and respectively 
gradient grade acetonitrile and sodium 
dihydrogen phosphate from Merck p.a. was 
used. Ultrapure water (resistivity of  18 Mȍ • 
cm) was obtained with the Ultra Clear TWF 
system 
(SG GmbH, Germany). 
 
Standard solutions 
Stock standard solution was prepared 
separately by oxytocin (about 100 IU / ml) in 
sodium phosphate buffer 0.13 M acid 
standard stock solution and chlorobutanol 
(12.5 mg/mL) in acetonitrile/water (1:1, v/v). 
About 10  mg oxytocin  reference 
substance with accurately of 0.1 mg it was 
weighed and dissolved in 50 mL volumetric 
flask and brought to volume with sodium 
phosphate buffer acid. Exact concentration of 
oxytocin in IU/ml was calculated, taking into 
account the declared content of oxytocin 
reference substance. 
Were weighed 625 mg of chlorobutanol 
reference substance, with the accuracy of 
0.1 mg, into a 50 ml graduated flask, by 
dissolving in acetonitrile-water (1:1, v/v) by 
sonication, and was diluted to volume and 
homogenized. Standard mixed calibration 
solutions were prepared by pipetting in 10 ml 
coted flasks of 0,25 ml, 0.5 ml, 1 ml, 1.5 ml 
and respectively 2 ml aliquots of stock 
standard oxytocin and 1,0 ml, 2.0 ml, 4.0 ml, 
6.0 ml and 8.0 ml of stock standard solution 
of chlorobutanol and fill to the mark with 
sodium dihydrogen phosphate buffer. 
It was calculated the exact content of 
oxytocin in IU/ml and chlorobutanol in mg/ml. 
Chlorobutanol and oxytocin concentrations 
from the calibration solutions corresponded 
approximately from 25% to 200% of the 
declared in the commercial product. 
 
HPLC analysis 
HPLC analysis was carried out on a 
Waters 2695 high performance liquid 
chromatograph equipped with an automatic 
injection thermostat-controlled temperature, 
ternary gradient pump system, the solvent 
degasser, auto sampler, PDA Detector 
(Waters 2998). 
Chromatographic separation was done 
on a C18 analytical column Syn Chropack 
RP100 (250mm x 4.6mm, 5 mm), maintained 
at 30 ϶C.  
The mobile phase consisted of 0.13 M 
dibasic sodium phosphate (solvent A) - 
acetonitrile: water (1:1, v/v) (solvent B) with 
the following concentration gradient: 30% B 
for 1 min, 30-60% B in 30 min, back to initial 
concentration, and 15 min equilibration 
before the next injection, at a rate of 1 
ml/min. The injection volume was 25 ¶. 
Detection was done at 220 nm.  
Assessment areas, regression analysis 
of the standard curve and concentrations 
calculation was made with Waters-Empower 
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Rezults and discussions 
 
Separation 
The first step were represented by the 
working conditions optimizing, in terms of 
analytical column, the pH of the mobile 
phase, the flow rate of the mobile phase, to 
obtain a corresponding shape of the peaks 
and proper separation between the oxytocin 
degradation and chlorobutanol degradation 
products. It was attempted to separate 
multiple reversed phase columns. 
A good resolution and a symmetrical 
shape of the peaks of the two compounds, 
oxytocin, and chlorobutanol, was obtained to 
Syn Chropack RP100, C18 column (250 x 
4.6 mm, 5 mm) with a mobile phase pH of 
3.0 and a flow rate 1 ml/min. In the 
conditions chosen it was obtained a retention 
time of 15.4 min for oxytocin and of 26.2 min 
for chlorobutanol. A typical chromatogram is 
given in figure 1.  
This column provides a resolution of 3.1 
between the peak of oxytocin and the 
nearest peak (Figure 3), higher than the 
requirement of the USP monograph, of 1.5 
min.  Resolution  of  oxytocin  and 
chlorobutanol is significant (R = 7.1). 
 
 
Nr.  Name  Retention Time  Area  % Area  Amount  Units  Start Time  End Time  Width 
1  Oxytocin  15.451  420408  34.34  10.000  UI/ml  15.147  16.338  71.500 
2  Clorobutanol  26.187  803726  65.66  5.000  mg/ml  25.737  27.583  110.800 
 
Figure 1. The chromatogram of the standard solution containing 10 IU / ml oxytocin and 5 mg / ml chlorobutanol 
 
 
Nr.  Name  Retention Time  Area  % Area  Height  Int Type  Amount  Units  Peak Type 
2  Oxytocin  15.438  417989  33.44  24645  BB  9.942  UI/ml  Found 
3  Clorobutanol  26.181  819440  65.58  21800  BB  5.098  mg/ml  Found 
 
Figure 2. The chromatogram of a commercial product of oxytocin injection 
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In Figure 2 the chromatogram of a 
commercial product formulated to contain 10 
IU/ml oxytocin and 5 mg/ml chlorobutanol is 
presented. 
 
Method’s validation 
The method was validated for the 
following parameters: selectivity, linearity and 
range of linearity, accuracy and precision. 
 
Selectivity 
The selectivity of the method was shown 
to interfere with other excipients present in 
the formulated product. 
Duplicate samples of the matrix (all 
components except the active ingredient of 
the commercial product (oxytocin) and 
preservative (chlorobutanol) were analyzed 
and no interference were observed at the 
retention time of oxytocin (abot 15 min) and 
chlorobutanol (about 26 min). 
Also  a  commercial product was 
subjected to stress through exposure to UV 
radiation. The resulting degradation products 
(6.25 min and 13.12 min), did not interfere 
with oxytocin and chlorobutanol peaks 
(Figure 3) 
 
 
Nr.  Name  Retention Time  Area  % Area  Amount  Units  Start Time  End Time  Width 
1  Peak 2  2.844  64677  5.54      2.757  3.217  27.600 
2  Peak4  5.579  20071  1.72      5.473  6.030  33.400 
3  Peak 5  6.249  66068  5.66      6.030  7.035  60.300 
4  Peak 6  13.125  23818  2.04      12.917  13.535  37.100 
5  Oxytocin  15.407  114041  9.77  2.713  UI/ml  15.145  16.002  51.400 
6  Clorbutanol  26.103  828650  71.03  5.155  mg/ml  25.700  27.398  101.900 
   
Figure 3. Chromatogram of a product subjected to degradation 
 
Linearity and linearity range 
Method’s linearity was evaluated by 
analyzing five different concentrations of 
standard solutions representing 25% to 
200% of the the predictable injectable 
products based on oxytocin. 
The results are shown in Table 1.  
Correlation coefficients (R2) of the 
calibration curves (Figure 4 and 5) are 
greater than 0.9950, which indicates an 
adequate linearity chosen fields (Miller & 
Miller, 1993). 
Table 1 
Linearity and range of linearity 
 
Component  Domeniu  EcuaĠia de regresie lineară  Coeficient de regresie 
lineară (r
2) 
Oxitocină  2,5 UI/ml – 20 UI/ml  y = 4.53e+004 x + 1.03e+004  0.999676 
Clorbutanol  1,25 mg/ml – 10 mg/ml  y = 1.79e+005 x - 1.93e+004  0.999982 
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Figure 4. The calibration curve for oxytocin from 2.5 IU/ml - 20 IU/ml 
 
 
 
Figure 5. Chlorobutanol calibration curves in 1.25 mg/ml - 10 mg/ml domain 
 
Exactity and fidelity  
The accuracy of the method was 
evaluated by analyzing six different samples 
on the same day and on different days.  
The relative standard deviation  for 
repeatability (RSD r) and the intermediate 
reproducible (RSD R) was below 2.0% 
(Table 2 and 3). 
Method’s fidelity was established by 
recovery experiments. For this purpose the 
blank (placebo  solution containing 0.4g of 
sodium chloride and 0.035g of acetic acid in 
100ml water) was added known amounts of 
oxytocin and chlorobutanol in order to obtain 
concentrations in the range of 25% -200% of 
the theoretical concentration commercial 
injectable products. 
There were calculated the recoveries 
that ranged from 98.3 to 102.6%, for oxytocin 
and  respectively  97.2  -102.1%  for 
chlorobutanol with the RDSR less than 2.0% 
(Table 4) 
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Table 2  
Repeatability Test results 
 
Components 
Sample 
Average   Sr 
RDSr 
%  1  2  3  4  5  6 
Oxytocin, UI/ml  9,89  10,25  10,12  9,98  10,07  10,15  10,08  0,127  1,27 
Chlorbutanol, mg/ml  4,88  5,08  5,06  4,95  4,92  5,01  4,98  0,08  1,60 
 
Table 3 
Ther esults of  intermediary reproducibility test  
 
Components  Day 1  Day 2  Day 3  Day 4  Day 5  Day 6  Average   SR 
RDSR 
% 
Oxytocin, UI/ml  10,25  10,11  9,86  10,05  10,24  9,91  10.07  0.46  1.62 
Chlorbutanol, mg/ml  5,08  4,98  5,14  5,12  5,03  4,88  5,04  0,10  1,93 
 
Table 4 
Recoveries for different levels of fortified control sample 
 
Components 
Fortification level  
(% of the theoretical value of the product) 
 
Average 
Recovery %  
SR 
RDSR 
% 
25%  50%  100%  150%  200% 
Oxytocin, UI/ml  102,6  99,8  98,3  101,5  98,8  100,2  1,82  1,81 
Chlorbutanol, mg/ml  102,1  99,8  100,3  98,2  97,2  99,8  2,00  2,00 
 
Conclusions 
 
Method of oxytocin and chlorobutanol 
analysis by HPLC technique allowed a 
proper  separation  of  oxytocin  from 
chlorobutanol and of oxytocin degradation 
substances. 
The method showed selectivity towards 
the other ingredients of the formulation.  
The method allows the simultaneous 
determination of oxytocin and chlorobutanol 
in a single injection into the HPLC. 
The method proved to be linear both for 
oxytocin and chlorobutanol, allowing the 
accurate determination of both components. 
The method is not affected by the small 
variations in flow, column temperature and 
pH of the aqueous phase and can be used 
for the quality control of oxytocin injectables. 
 
References 
 
1.  The European Pharmacopoeia 7.0 (2008), 
Monograph of oxytocin concentrated solution 
01/2008:0779.  
2. US  Pharmacopoeia  31,  (2008).  Oxytocin 
monograph. 
3.  DIONEX Application Note 234. Simultaneous 
Determination of Pharmaceutical Peptides and 
Acetate by HPLC with UV Detection using the 
Acclaim Mixed-Mode WAX-1 column, 2009. 
4.  Wang G, Miller RB, Melendez L, Iacobus R 
(1997). A stability-indicating HPLC method for the 
determination of oxytocin acetate in oxytocin 
injection,  USP,  synthetic,  Journal  of  Liquid 
Chromatography and Related Technologies 20:: 
567-581. 
5.  Suresh K,  Kavitha MP,  Dharuman J, 
Dhandapani  B  (2010).  RP-HPLC  method 
development and validation for the estimation of 
oxytocin  in  milk,  International  Journal  of 
ChemTech Research, 2,(2): 1340-1343. 
6.  Sudhakar Ryali, Varaprasad Bobbarala (2011). 
Development and validation of a stability-indicating 
analytical method for the quantitation of oxytocin,  
International Journal of Chemical and Analytical 
Science, 2(10): 1222-1225. 
 